TWD 60.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.66 Million TWD | 0.0% |
2022 | - TWD | 0.0% |
2021 | - TWD | 0.0% |
2020 | - TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - TWD | -100.0% |
2024 Q2 | -1.1 Million TWD | 0.0% |
2023 Q1 | - TWD | 0.0% |
2023 FY | 6.66 Million TWD | 0.0% |
2023 Q4 | 3.33 Million TWD | 0.0% |
2023 Q3 | 3.33 Million TWD | 0.0% |
2023 Q2 | - TWD | 0.0% |
2022 FY | - TWD | 0.0% |
2022 Q4 | - TWD | 0.0% |
2022 Q3 | - TWD | 0.0% |
2021 FY | - TWD | 0.0% |
2020 FY | - TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 98.344% |
Level Biotechnology Inc. | 219.54 Million TWD | 96.963% |
Sagittarius Life Science Corp | 71.47 Million TWD | 90.673% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 173.385% |
TaiMed Biologics Inc. | 225.23 Million TWD | 97.04% |
GlycoNex Incorporation | 995 Thousand TWD | -570.05% |
VBI | 16.42 Million TWD | 59.404% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 75.83% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 96.641% |
Visgeneer Inc. | 67.48 Million TWD | 90.12% |
Mycenax Biotech Inc. | -375.19 Million TWD | 101.777% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.525% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 95.389% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 97.104% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 70.684% |
Enimmune corporation | -23.37 Million TWD | 128.524% |
TaiRx, Inc. | 2.43 Million TWD | -173.35% |
CHO Pharma, Inc. | -28.27 Million TWD | 123.576% |
EirGenix Inc. | 236.74 Million TWD | 97.184% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 93.611% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 97.665% |
Lin BioScience, Inc. | -17.92 Million TWD | 137.19% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 92.561% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 91.741% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -515.605% |
Lukas Biomedical Inc. | 133.89 Million TWD | 95.021% |
RBC Bioscience Corporation | 72.89 Million TWD | 90.854% |
BiOptic Inc. | 152.74 Million TWD | 95.635% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -7307.778% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -154.952% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 98.965% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -1926.444% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -1179.655% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 94.44% |
Neith Corporation | 18.01 Million TWD | 63.0% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 155.549% |
NaviFUS Corp. | 11.82 Million TWD | 43.629% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 93.111% |
Sinew Pharma Inc. | -28.98 Million TWD | 123.002% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -2030.032% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 98.301% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 83.928% |
AP Biosciences Inc | 32.25 Million TWD | 79.329% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 98.92% |
3D Global Biotech Inc. | 5.27 Million TWD | -26.413% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 97.88% |
Intech Biopharm Corporation | -163.99 Million TWD | 104.065% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 79.525% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 265.475% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 168.457% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 98.625% |
TCI GENE Inc. | 174.61 Million TWD | 96.182% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 140.16% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 165.536% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 91.269% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 91.337% |
PharmaEngine, Inc. | 718.97 Million TWD | 99.073% |
Savior Lifetec Corporation | 220.94 Million TWD | 96.983% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 94.031% |
OBI Pharma, Inc. | -73.49 Million TWD | 109.071% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 95.199% |
Acepodia, Inc. | 16.59 Million TWD | 59.82% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 75.729% |